| RS1562845204 |
TFR2
|
Health Risk |
Likely pathogenic |
Hereditary hemochromatosis, Hereditary hemochromatosis |
| RS1562846113 |
PEX1
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Zellweger spectrum disorders |
| RS1562846257 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Peroxisome biogenesis disorder 1B |
| RS1562846694 |
ACTL6B
|
Health Risk |
Likely pathogenic |
ACTL6B-related neurodevelopmental disorder, ACTL6B-related neurodevelopmental disorder |
| RS1562847147 |
TNXB
|
Health Risk |
Likely pathogenic |
— |
| RS1562847909 |
ACTL6B
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 76 |
| RS1562847911 |
PEX1
|
Health Risk |
Likely pathogenic |
Zellweger spectrum disorders, Peroxisome biogenesis disorder 1B |
| RS1562848142 |
ACTL6B
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 76 |
| RS1562848425 |
ACTL6B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 76 |
| RS1562848466 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562848479 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562848556 |
ACTL6B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 76 |
| RS1562848568 |
ACTL6B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 76 |
| RS1562848909 |
ACTL6B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 76 |
| RS1562849964 |
RINT1
|
Health Risk |
Pathogenic |
Fulminant hepatic failure, Infantile liver failure syndrome 3 |
| RS1562851618 |
TNXB
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome due to tenascin-X deficiency |
| RS1562852978 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1562853011 |
SGCE
|
Health Risk |
Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1562853874 |
RINT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1562857198 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Zellweger spectrum disorders |
| RS1562857871 |
PEX1
|
Health Risk |
Pathogenic |
— |
| RS1562864687 |
CASD1;SGCE
|
Health Risk |
Likely pathogenic |
— |
| RS1562867409 |
PEX1
|
Health Risk |
Pathogenic |
Heimler syndrome 1, Heimler syndrome 1 |
| RS1562869207 |
SYNGAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1562875556 |
CUX1
|
Health Risk |
Likely pathogenic |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS1562876396 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562876459 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS1562881854 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562881859 |
CCM2
|
Health Risk |
Likely pathogenic |
— |
| RS1562881980 |
CCM2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1562882045 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562882049 |
CCM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562882675 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562882755 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562883374 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1562883575 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS1562884016 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1562884046 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562889180 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562889382 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562889397 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1562889435 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1562890223 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562891084 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562892108 |
CFTR
|
Health Risk |
Likely pathogenic |
— |
| RS1562892293 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1562892359 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562892387 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562892823 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562892895 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562894320 |
PLOD3
|
Health Risk |
Likely pathogenic |
Bone fragility with contractures, arterial rupture |
| RS1562894926 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1562894928 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562895009 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1562895052 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1562895066 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562895104 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562895128 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562897434 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia, type II |
| RS1562898465 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562898471 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562898489 |
CFTR;CFTR-AS1
|
Health Risk |
Likely pathogenic |
Hereditary pancreatitis, Cystic fibrosis |
| RS1562898496 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562898510 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562899031 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1562900513 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1562905085 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1562905224 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1562905246 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1562906013 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta type III |
| RS1562906265 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562906570 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS1562906798 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562906981 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562907186 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1562907190 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1562907232 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562907260 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562907287 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS1562907331 |
CCM2
|
Health Risk |
Likely pathogenic |
— |
| RS1562907365 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562907455 |
CCM2
|
Health Risk |
Pathogenic |
— |
| RS1562907873 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562907896 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562907979 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562908173 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1562908889 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562908997 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
CFTR-related disorder, Bronchiectasis with or without elevated sweat chloride 1 |
| RS1562911661 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562911739 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562912305 |
AP4M1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 50, Intellectual disability |
| RS1562912426 |
CCM2
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562912441 |
CCM2
|
Health Risk |
Likely pathogenic |
CCM2-related disorder, CCM2-related disorder |
| RS1562912528 |
CCM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562913873 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562914028 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562914072 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562914082 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562914107 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562914200 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |